Plygersic….a product from Phlai and ginger extracts for joint pain relief of osteoarthritis
Successful in conducting R&D of “Plygersic” from the extracts of Phlai (Zingiber cassumunar) and ginger (Zingiber officinale). The product was used for treating joint inflammation caused by osteoarthritis. The quality of the product was scientifically justified by essential testing such as pharmaceutical, product safety and clinical tests. The efficiency and safety test in patients was also undertaken in collaboration with Faculty of Medicine, Thammasat University. The clinical study of Plygersic in osteoarthritis patients aged 35 years old up showed that the result was significantly better than gel base in reducing the inflammation, pain, stiffness, and limited range of motion in the knee which caused difficulties in sitting and standing, going up and down the stairs, stepping out of or inside a car or bending for grapping things. No effects were found in gastrointestinal tract, liver and kidney. The marketing trial also showed that the target group was satisfied with the product’s colour, odour, and gel texture, and mostly satisfied with absorption. The business plan study showed that the investment would be cost effective as the product had some uniqueness which was different from other types in the market, thus it has high potential to be commercialized.